Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-770P is a processed pseudogene derived from the U6 small nuclear RNA gene. U6 snRNA itself is an essential noncoding RNA that functions as part of small nuclear ribonucleoproteins (snRNPs) for pre-mRNA splicing in the spliceosome[3][5]. The RNU6-770P pseudogene is a nonfunctional sequence arising from retrotransposition, lacks a promoter, and is not transcribed or translated into a functional product[2][4]. Pseudogenes like RNU6-770P are common genomic elements and do not encode protein or functional RNAs. While some pseudogenes can act as regulatory RNAs and participate in gene networks, there is no evidence that RNU6-770P possesses such roles, nor is it a disease-related or therapeutically relevant entity[4].
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 770, pseudogene (RNU6-770P).